HLS Therapeutics (HLS Therapeutics) Other Long-Term Liabilities : $1.77 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is HLS Therapeutics Other Long-Term Liabilities?

HLS Therapeutics's other long-term liabilities for the quarter that ended in Dec. 2023 was $1.77 Mil.

HLS Therapeutics's quarterly other long-term liabilities increased from Jun. 2023 ($1.83 Mil) to Sep. 2023 ($2.20 Mil) but then declined from Sep. 2023 ($2.20 Mil) to Dec. 2023 ($1.77 Mil).

HLS Therapeutics's annual other long-term liabilities declined from Dec. 2021 ($1.88 Mil) to Dec. 2022 ($0.82 Mil) but then increased from Dec. 2022 ($0.82 Mil) to Dec. 2023 ($1.77 Mil).

HLS Therapeutics Other Long-Term Liabilities Historical Data

The historical data trend for HLS Therapeutics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLS Therapeutics Other Long-Term Liabilities Chart

HLS Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

HLS Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

HLS Therapeutics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

HLS Therapeutics Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of HLS Therapeutics's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

HLS Therapeutics (HLS Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (OTCPK:HLTRF) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

HLS:Canada

Address

10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W6L2

Website

https://www.hlstherapeutics.com

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of the world.

HLS Therapeutics (HLS Therapeutics) Headlines

From GuruFocus

Automodular Corp. (TSX:AM) - Strong Buy

By Elliot Luchansky, CFA Elliot Luchansky, CFA • 03-21-2013